Scinai Immunotherapeutics Files 2024 Annual Report
Ticker: SCNI · Form: 20-F · Filed: May 7, 2025 · CIK: 1611747
| Field | Detail |
|---|---|
| Company | Scinai Immunotherapeutics Ltd. (SCNI) |
| Form Type | 20-F |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, biotech, sec-filing
TL;DR
Scinai Immunotherapeutics filed its 2024 20-F, check financials.
AI Summary
Scinai Immunotherapeutics Ltd. filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, formerly known as BiondVax Pharmaceuticals Ltd. until June 24, 2014, is based in Jerusalem, Israel, and operates in the biological products sector. The filing was made on May 7, 2025.
Why It Matters
This filing provides investors with a comprehensive overview of Scinai Immunotherapeutics' financial performance and business operations for the fiscal year 2024, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, Scinai Immunotherapeutics is subject to inherent risks related to drug development, clinical trials, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- 20250507 — Filing Date (The date the 20-F was submitted to the SEC.)
Key Players & Entities
- Scinai Immunotherapeutics Ltd. (company) — Filer of the 20-F
- BiondVax Pharmaceuticals Ltd. (company) — Former name of Scinai Immunotherapeutics Ltd.
- 20250507 (date) — Filing date of the 20-F
- 20241231 (date) — Fiscal year end date
- 001-37353 (dollar_amount) — SEC file number
FAQ
What is the primary business of Scinai Immunotherapeutics Ltd.?
Scinai Immunotherapeutics Ltd. is in the business of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
When did Scinai Immunotherapeutics Ltd. change its name from BiondVax Pharmaceuticals Ltd.?
The company changed its name from BiondVax Pharmaceuticals Ltd. on June 24, 2014.
What is the SEC file number for Scinai Immunotherapeutics Ltd.'s filing?
The SEC file number for this filing is 001-37353.
Where is Scinai Immunotherapeutics Ltd. located?
Scinai Immunotherapeutics Ltd. is located at Jerusalem Biopark, 2nd Floor, Hassadah Ein Kerem Campus, Jerusalem.
What type of SEC filing is this document?
This document is an Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, specifically a Form 20-F.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on May 7, 2025 regarding Scinai Immunotherapeutics Ltd. (SCNI).